4.8 Article

Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation

期刊

NATURE CELL BIOLOGY
卷 12, 期 10, 页码 963-972

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2098

关键词

-

资金

  1. Cancer Research UK
  2. Medical Research Council [G0901677] Funding Source: researchfish
  3. MRC [G0901677] Funding Source: UKRI

向作者/读者索取更多资源

The AP-1 transcription factor c-Jun is essential for cellular proliferation in many cell types, but the molecular link between growth factors and c-Jun activation has been enigmatic. In this study we identify a previously uncharacterized RING-domain-containing protein, RACO-1 (RING domain AP-1 co-activator-1), as a c-Jun co-activator that is regulated by growth factor signalling. RACO-1 interacted with c-Jun independently of amino-terminal phosphorylation, and was both necessary and sufficient for c-Jun/AP-1 activation. Growth factor-mediated stimulation of AP-1 was attributable to MEK/ERK-dependent stabilization of RACO-1 protein. Stimulation of the MEK/ERK pathway strongly promoted Lys 63-linked ubiquitylation of RACO-1, which antagonized Lys 48-linked degradative auto-ubiquitylation of the same Lys residues. RACO-1 depletion reduced cellular proliferation and decreased expression of several growth-associated AP-1 target genes, such as cdc2, cyclinD1 and hb-egf. Moreover, transgenic overexpression of RACO-1 augmented intestinal tumour formation triggered by aberrant Wnt signalling and cooperated with oncogenic Ras in colonic hyperproliferation. Thus RACO-1 is a co-activator that links c-Jun to growth factor signalling and is essential for AP-1 function in proliferation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner

Monika M. Gladka, Arwa Kohela, Bas Molenaar, Danielle Versteeg, Lieneke Kooijman, Jantine Monshouwer-Kloots, Veerle Kremer, Harmjan R. Vos, Manon M. H. Huibers, Jody J. Haigh, Danny Huylebroeck, Reinier A. Boon, Mauro Giacca, Eva van Rooij

Summary: ZEB2 is a beneficial transcription factor that induces cardioprotective effects in a subset of stressed cardiomyocytes. Therapeutic delivery of ZEB2 to cardiomyocytes prevents cardiac dysfunction after ischemic damage and promotes the activation of pro-angiogenic signals.

NATURE COMMUNICATIONS (2021)

Article Cardiac & Cardiovascular Systems

Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis

Willeke de Haan, Wouter Dheedene, Katerina Apelt, Sofiane Decombas-Deschamps, Stefan Vinckier, Stefaan Verhulst, Andrea Conidi, Thomas Deffieux, Michael W. Staring, Petra Vandervoort, Ellen Caluwe, Marleen Lox, Inge Mannaerts, Tsuyoshi Takagi, Joris Jaekers, Geert Berx, Jody Haigh, Baki Topal, An Zwijsen, Yujiro Higashi, Leo A. van Grunsven, Wilfred F. J. van IJcken, Eskeatnaf Mulugeta, Mickael Tanter, Franck P. G. Lebrin, Danny Huylebroeck, Aernout Luttun

Summary: This study demonstrated the specific role of Zeb2 in liver endothelial cells, showing that Zeb2 deficiency leads to significant changes in gene expression related to angiogenesis and potential promotion of endothelial dedifferentiation. Furthermore, Zeb2 regulates LSEC-HSC communication and HSC activation to maintain vascular structure and inhibit liver fibrosis.

CARDIOVASCULAR RESEARCH (2022)

Article Multidisciplinary Sciences

Peripheral-specific Y1 receptor antagonism increases thermogenesis and protects against diet-induced obesity

Chenxu Yan, Tianshu Zeng, Kailun Lee, Max Nobis, Kim Loh, Luoning Gou, Zefeng Xia, Zhongmin Gao, Mohammed Bensellam, Will Hughes, Jackie Lau, Lei Zhang, Chi Kin Ip, Ronaldo Enriquez, Hanyu Gao, Qiao-Ping Wang, Qi Wu, Jody J. Haigh, D. Ross Laybutt, Paul Timpson, Herbert Herzog, Yan-Chuan Shi

Summary: Blocking Y1 receptors in peripheral tissues using selective antagonists can reduce weight gain, decrease fat mass, and improve glucose metabolism, suggesting a potential safer and more effective treatment for diet-induced obesity.

NATURE COMMUNICATIONS (2021)

Article Cell & Tissue Engineering

Ductal Ngn3-expressing progenitors contribute to adult β cell neogenesis in the pancreas

Christopher Gribben, Christopher Lambert, Hendrik A. Messal, Ella-Louise Hubber, Chloe Rackham, Ian Evans, Harry Heimberg, Peter Jones, Rocio Sancho, Axel Behrens

Summary: Ductal cells have been identified as a source of adult beta cell neogenesis, contributing to the beta cell population over time. The expression of Ngn3 in ductal cells plays a role in adult beta cell neogenesis, potentially impacting diabetes onset. Additionally, single-cell RNA sequencing revealed duct-derived somatostatin-expressing cells gave rise to beta cells.

CELL STEM CELL (2021)

Article Medicine, Research & Experimental

Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias

Jose Gonzalez-Martinez, Andrzej W. Cwetsch, Diego Martinez-Alonso, Luis R. Lopez-Sainz, Jorge Almagro, Anna Melati, Jesus Gomez, Manuel Perez-Martinez, Diego Megias, Jasminka Boskovic, Javier Gilabert-Juan, Osvaldo Grana-Castro, Alessandra Pierani, Axel Behrens, Sagrario Ortega, Marcos Malumbres

Summary: The study reveals that defects in certain genes during development can lead to mild MCPH symptoms, while the lack of centrosome or centriole regulators can cause chromosomal instability in neural progenitor cells.

JCI INSIGHT (2021)

Article Medicine, Research & Experimental

JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer

E. Josue Ruiz, Linxiang Lan, Markus Elmar Diefenbacher, Eva Madi Riising, Clive Da Costa, Atanu Chakraborty, Joerg D. Hoeck, Bradley Spencer-Dene, Gavin Kelly, Jean-Pierre David, Emma Nye, Julian Downward, Axel Behrens

Summary: In a mouse model of K-RasG12D-induced lung adenocarcinoma, deletion or mutation of c-Jun unexpectedly increased lung tumor burden, while the Jun family member JunD was found to be crucial in JNK signaling and Ras-induced lung cancer in the absence of c-Jun.

JCI INSIGHT (2021)

Article Biochemistry & Molecular Biology

METTL3 promotes oxaliplatin resistance of gastric cancer CD133+stem cells by promoting PARP1 mRNA stability

Huafu Li, Chunming Wang, Linxiang Lan, Leping Yan, Wuguo Li, Ian Evans, E. Josue Ruiz, Qiao Su, Guangying Zhao, Wenhui Wu, Haiyong Zhang, Zhijun Zhou, Zhenran Hu, Wei Chen, Joaquim M. Oliveira, Axel Behrens, Rui L. Reis, Changhua Zhang

Summary: In this study, the researchers investigated the mechanism of oxaliplatin resistance in gastric cancer using in vitro human gastric cancer organoids and oxaliplatin-resistant cell lines, as well as in vivo tumorigenicity experiments. They found that CD133+ stem cell-like cells are the main subpopulation associated with resistance, and that the gene PARP1 plays a central role in mediating this resistance. The researchers discovered that PARP1 can effectively repair DNA damage caused by oxaliplatin by activating the base excision repair pathway, leading to the development of drug resistance. They also found that CD133+ cells exhibit increased expression of the mRNA modification N6-methyladenosine (m6A) and its writer METTL3, which enhances the stability of PARP1 and contributes to its DNA damage repair ability. Overall, this study demonstrates that m6A methyltransferase METTL3 promotes oxaliplatin resistance in CD133+ gastric cancer stem cells by increasing PARP1 mRNA stability and base excision repair activity.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Biochemistry & Molecular Biology

The Jun-dependent axon regeneration gene program: Jun promotes regeneration over plasticity

Matthew R. J. Mason, Susan van Erp, Kim Wolzak, Axel Behrens, Gennadij Raivich, Joost Verhaagen

Summary: The regeneration-associated gene expression program is crucial for axon re-growth in injured peripheral neurons. Jun, a transcription factor, plays an important role in regulating this program by upregulating gene expression and promoting cell regeneration while inhibiting plasticity response.

HUMAN MOLECULAR GENETICS (2022)

Article Multidisciplinary Sciences

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

Jessica K. Nelson, May Zaw Thin, Theodore Evan, Steven Howell, Mary Wu, Bruna Almeida, Nathalie Legrave, Duco S. Koenis, Gabriela Koifman, Yoichiro Sugimoto, Miriam Llorian Sopena, James MacRae, Emma Nye, Michael Howell, Ambrosius P. Snijders, Andreas Prachalias, Yoh Zen, Debashis Sarker, Axel Behrens

Summary: This study reveals that the deubiquitinating enzyme USP25 promotes growth and survival of pancreatic ductal adenocarcinoma (PDAC) by stabilizing and regulating the transcriptional activity of HIF-1 protein. PDAC is characterized by a severely hypoxic microenvironment, and inhibition of USP25 impairs HIF-1 activity and induces cell death in the tumor core. The USP25/HIF-1α axis may be a potential therapeutic target for PDAC.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

Linxiang Lan, Theodore Evan, Huafu Li, Aasia Hussain, E. Josue Ruiz, May Zaw Thin, Rute M. M. Ferreira, Hari Ps, Eva M. Riising, Yoh Zen, Jorge Almagro, Kevin W. Ng, Pablo Soro-Barrio, Jessica Nelson, Gabriela Koifman, Joana Carvalho, Emma L. Nye, Yulong He, Changhua Zhang, Anguraj Sadanandam, Axel Behrens

Summary: This study identifies BMP inhibitor GREM1 as a key regulator of cellular heterogeneity in pancreatic cancer. Continuous activity of GREM1 is required to maintain the stability of the epithelial PDAC subpopulations, while high activity of GREM1 can revert the mesenchymal fate of PDAC cells. By inhibiting the expression of epithelial-mesenchymal transition transcription factors, GREM1 restricts the epithelial-mesenchymal plasticity of pancreatic cancer cells.

NATURE (2022)

Article Oncology

JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL

Aissa Benyoucef, Katharina Haigh, Andrew Cuddihy, Jody J. Haigh

Summary: ETP-ALL is a high-risk subtype of T cell acute lymphoblastic leukemia that often relapses after conventional chemotherapy. In this study, the authors discovered the novel involvement of ZEB2/LSD1 complexes in repressing the intrinsic apoptosis pathway and identified BIM as a major driver for ETP-ALL survival. Treatment with LSD1 inhibitors restored the expression of BIM and, when combined with other inhibitors, reversed the resistance of ETP-ALL to LSD1 inhibitors, leading to inhibited growth and enhanced differentiation of ETP-ALL cells.

LEUKEMIA (2022)

Review Oncology

DNA Repair and Therapeutic Strategies in Cancer Stem Cells

Matthew S. Gillespie, Ciara M. Ward, Clare C. Davies

Summary: Cancer stem cells (CSCs) play a crucial role in cancer development, progression, metastasis, and relapse. They are highly drug resistant due to enhanced DNA repair efficiency. This review discusses the mechanisms of CSC drug resistance and strategies for targeting the DNA damage response to improve cancer treatment efficacy.

CANCERS (2023)

Article Biology

annotate_my_genomes: an easy-to-use pipeline to improve genome annotation and uncover neglected genes by hybrid RNA sequencing

Carlos Farkas, Antonia Recabal, Andy Mella, Daniel Candia-Herrera, Maryori Gonzalez Olivero, Jody Jonathan Haigh, Estefania Tarifeno-Saldivia, Teresa Caprile

Summary: This study developed a genome-guided transcriptome annotation pipeline that integrates various bioinformatics approaches to accurately annotate the transcriptome and identify new genes and homologous species.

GIGASCIENCE (2022)

Review Oncology

Tissue architecture in tumor initiation and progression

Jorge Almagro, Hendrik A. Messal, Alberto Elosegui-Artola, Jacco van Rheenen, Axel Behrens

Summary: The 3D architecture of tissues bearing tumors has significant impacts on the mechanical microenvironment of cancer, the accessibility of stromal cells, and the routes of invasion. Various forces from cancer cells, host tissue, and the molecular and cellular microenvironment modulate the morphology and malignant potential of the tumor through mechanical, biochemical, genetic, and epigenetic cues. Recent studies have revealed how tissue architecture influences cancer biology and progression.

TRENDS IN CANCER (2022)

Review Oncology

Tissue clearing to examine tumour complexity in three dimensions

Jorge Almagro, Hendrik A. Messal, May Zaw Thin, Jacco van Rheenen, Axel Behrens

Summary: The visualization of whole organs and organisms through tissue clearing and fluorescence volumetric imaging has revolutionized the way we study biological samples, particularly in tumor research and cancer diagnostics.

NATURE REVIEWS CANCER (2021)

暂无数据